Wells Fargo’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,595
| Closed | -$53.6K | – | 6530 |
|
|
2024
Q1 | $53.6K | Buy |
15,595
+2,005
| +15% | +$6.9K | ﹤0.01% | 4855 |
|
|
2023
Q4 | $33.4K | Buy |
13,590
+2,689
| +25% | +$6.62K | ﹤0.01% | 5005 |
|
|
2023
Q3 | $18.5K | Sell |
10,901
-5,966
| -35% | -$10.1K | ﹤0.01% | 5265 |
|
|
2023
Q2 | $50.6K | Buy |
16,867
+16,552
| +5,255% | +$49.7K | ﹤0.01% | 5143 |
|
|
2023
Q1 | $844 | Buy |
315
+4
| +1% | +$11 | ﹤0.01% | 6107 |
|
|
2022
Q4 | $2.57K | Buy |
311
+73
| +31% | +$602 | ﹤0.01% | 5624 |
|
|
2022
Q3 | $1K | Buy |
238
+25
| +12% | +$105 | ﹤0.01% | 5941 |
|
|
2022
Q2 | $0 | Sell |
213
-94
| -31% | – | ﹤0.01% | 6490 |
|
|
2022
Q1 | $1K | Sell |
307
-5,491
| -95% | -$17.9K | ﹤0.01% | 6396 |
|
|
2021
Q4 | $114K | Buy |
5,798
+5,741
| +10,072% | +$113K | ﹤0.01% | 5170 |
|
|
2021
Q3 | $1K | Sell |
57
-1
| -2% | -$18 | ﹤0.01% | 6320 |
|
|
2021
Q2 | $2K | Sell |
58
-3,558
| -98% | -$123K | ﹤0.01% | 6183 |
|
|
2021
Q1 | $184K | Buy |
+3,616
| New | +$184K | ﹤0.01% | 4873 |
|